BRIEF-EMA Starts Evaluating Use Of Booster Dose Of Nuvaxovid In Adults

European Medicines Agency:

* EMA: EMA STARTED EVALUATING THE USE OF A BOOSTER DOSE OF NOVAVAX'S COVID-19 VACCINE, NUVAXOVID, IN ADULTS: 20/05/2022 Further company coverage:

(This story has not been edited by Devdiscourse staff and is auto-generated from a syndicated feed.)